CLOs on the Move

Orbus Therapeutics

www.orbustherapeutics.com

 
Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million

Executives

Name Title Contact Details

Similar Companies

Gencom Group

Gencom Group is one of the leading providers in Healthcare, Pharmaceuticals, & Biotech. It is based in Miami, FL. To find more information about Gencom Group, please visit www.gencomgrp.com

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.

Stroops Fitness Ctr

Stroops Fitness Ctr is a Clearfield, UT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Canadian Association of Gastroenterology

Canadian Association of Gastroenterology is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

GuideWell

GuideWell Source is a leading administrative services company providing full-service, end-to-end business services for health plans and government sponsored health care programs.